Compare · NOW vs PEAR
NOW vs PEAR
Side-by-side comparison of ServiceNow Inc. (NOW) and Pear Therapeutics Inc. (PEAR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NOW and PEAR operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- NOW is the larger of the two at $110.29B, about 205.7x PEAR ($536.0M).
- NOW has hit the wire 22 times in the past 4 weeks while PEAR has been quiet.
- NOW has more recent analyst coverage (25 ratings vs 6 for PEAR).
- Company
- ServiceNow Inc.
- Pear Therapeutics Inc.
- Price
- $106.50-0.47%
- $0.03-36.03%
- Market cap
- $110.29B
- $536.0M
- 1M return
- +16.56%
- -
- 1Y return
- -47.23%
- -
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NYSE
- NASDAQ
- IPO
- 2012
- 2021
- News (4w)
- 22
- 0
- Recent ratings
- 25
- 6
ServiceNow Inc.
ServiceNow, Inc. provides enterprise cloud computing solutions that defines, structures, consolidates, manages, and automates services for enterprises worldwide. It operates the Now platform that offers workflow automation, artificial intelligence, machine learning, performance analytics, electronic service catalogs and portals, configuration management systems, data benchmarking, encryption, and collaboration and development tools. The company also provides information technology (IT) service management applications; IT service management product suite for enterprise's employees, customers, and partners; IT business management product suite to manage IT priorities; IT operations management product that connects a customer's physical and cloud-based IT infrastructure; IT Asset Management to automate IT asset lifecycles; and enterprise development operations product for developers' toolchain. In addition, it offers security incident management, threat enrichment intelligence, vulnerability response management, and security incident intelligence sharing security operation products; governance, risk, and compliance product to create policies and controls; human resources, legal, and workplace service delivery products; safe workplace applications; customer service management product; and field service management applications. Further, it provides App Engine product; IntegrationHub enables application to extend workflows; and professional, training, and customer support services. It serves government, financial services, healthcare, telecommunications, manufacturing, IT services, technology, oil and gas, education, and consumer products. It sells its products through direct sales team and resale partners. The company was formerly known as Service-now.com and changed its name to ServiceNow, Inc. in May 2012. The company was incorporated in 2004 and is headquartered in Santa Clara, California.
Pear Therapeutics Inc.
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
Latest NOW
- City Year Receives $2.5M Grant from ServiceNow to Power Student Success and Build Future-Ready Talent Pipelines
- Director Briggs Teresa sold $173,376 worth of shares (1,595 units at $108.70), decreasing direct ownership by 13% to 11,010 units (SEC Form 4)
- SEC Form 3 filed by new insider Yuan Eric S.
- Director Luddy Frederic B was granted 3,260 shares, increasing direct ownership by 204% to 4,855 units (SEC Form 4)
- Director Chamberlain Paul Edward was granted 3,260 shares, increasing direct ownership by 7% to 48,190 units (SEC Form 4)
- Director Briggs Teresa was granted 3,260 shares, increasing direct ownership by 35% to 12,605 units (SEC Form 4)
- Director Jackson Lawrence was granted 3,260 shares, increasing direct ownership by 202% to 4,875 units (SEC Form 4)
- Director Sands Anita M was granted 3,260 shares, increasing direct ownership by 11% to 33,350 units (SEC Form 4)
- Director Bostrom Susan L was granted 3,260 shares, increasing direct ownership by 18% to 21,685 units (SEC Form 4)
- Director Quinlan Larry was granted 3,260 shares, increasing direct ownership by 40% to 11,465 units (SEC Form 4)
Latest PEAR
- SEC Form 25-NSE filed by Pear Therapeutics Inc.
- SEC Form SC 13D/A filed by Pear Therapeutics Inc. (Amendment)
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Stocks That Hit 52-Week Lows On Tuesday
- Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Monday
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket